health π¬ One-dose drug could end malaria infections
Researchers at the University of Illinois Chicago have developed a new oral antimalarial drug that successfully eliminated malaria parasites in animal studies. The drug was tested on mice infected with Plasmodium yoelii, a model for human malaria. It targets dormant parasites and shows no signs of inducing drug resistance in initial tests. Malaria currently affects about 250 million people annually, causing over 600,000 deaths globally. The team is now seeking NIH funding to advance the compound toward human trials. π¬